Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,024 | 1,021 | 99.8% |
| Education | $38.99 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,091 | 122 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,699 | 91 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,667 | 104 | $0 (2024) |
| ABBVIE INC. | $1,605 | 102 | $0 (2024) |
| Amgen Inc. | $1,190 | 74 | $0 (2024) |
| PFIZER INC. | $972.56 | 76 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $651.58 | 45 | $0 (2023) |
| Allergan, Inc. | $624.95 | 64 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $445.42 | 32 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $374.27 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,444 | 133 | ABBVIE INC. ($381.62) |
| 2023 | $2,146 | 126 | ABBVIE INC. ($354.38) |
| 2022 | $2,147 | 123 | ABBVIE INC. ($462.14) |
| 2021 | $2,296 | 140 | AbbVie Inc. ($367.37) |
| 2020 | $1,761 | 110 | AstraZeneca Pharmaceuticals LP ($308.07) |
| 2019 | $1,187 | 72 | AstraZeneca Pharmaceuticals LP ($211.98) |
| 2018 | $2,000 | 150 | AstraZeneca Pharmaceuticals LP ($324.95) |
| 2017 | $2,081 | 170 | GlaxoSmithKline, LLC. ($331.58) |
All Payment Transactions
1,024 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Oncology | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Oncology | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Oncology | ||||||
| 10/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Obesity | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,010 | 3,193 | $354,063 | $80,739 |
| 2022 | 21 | 2,439 | 3,958 | $511,252 | $111,999 |
| 2021 | 21 | 2,846 | 4,621 | $601,712 | $127,696 |
| 2020 | 29 | 3,143 | 4,920 | $690,953 | $135,083 |
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 344 | 565 | $119,971 | $30,892 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 285 | 354 | $109,493 | $22,593 | 20.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 98 | $11,714 | $4,233 | 36.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 365 | 563 | $27,140 | $4,223 | 15.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 315 | 498 | $5,652 | $2,991 | 52.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 41 | 41 | $10,332 | $2,877 | 27.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 79 | $11,618 | $2,344 | 20.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $7,398 | $1,789 | 24.2% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 11 | 11 | $7,060 | $1,538 | 21.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 365 | 601 | $8,350 | $1,300 | 15.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 44 | $4,360 | $1,251 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $4,996 | $1,210 | 24.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 54 | 56 | $7,632 | $1,154 | 15.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 115 | $11,254 | $1,036 | 9.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 17 | $2,169 | $701.76 | 32.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 31 | $2,217 | $262.25 | 11.8% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 12 | 13 | $1,757 | $202.80 | 11.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 16 | 16 | $753.95 | $122.01 | 16.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 14 | 64 | $197.04 | $20.31 | 10.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 378 | 538 | $166,823 | $40,883 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 420 | 774 | $163,422 | $37,402 | 22.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 66 | 66 | $15,852 | $4,520 | 28.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 22 | 107 | $18,990 | $4,069 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 36 | $14,972 | $3,997 | 26.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 403 | 643 | $25,000 | $3,913 | 15.7% |
About Dr. Robert Gaston, MD
Dr. Robert Gaston, MD is a Family Medicine healthcare provider based in Hermitage, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003897380.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Gaston, MD has received a total of $16,063 in payments from pharmaceutical and medical device companies, with $2,444 received in 2024. These payments were reported across 1,024 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($16,024).
As a Medicare-enrolled provider, Gaston has provided services to 10,438 Medicare beneficiaries, totaling 16,692 services with total Medicare billing of $455,517. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hermitage, TN
- Active Since 11/14/2005
- Last Updated 05/02/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1003897380
Products in Payments
- VRAYLAR (Drug) $990.62
- FARXIGA (Drug) $968.68
- TRELEGY ELLIPTA (Drug) $911.25
- Ozempic (Drug) $728.00
- NURTEC ODT (Drug) $658.27
- XARELTO (Drug) $578.11
- Otezla (Drug) $504.10
- QULIPTA (Drug) $432.84
- XIFAXAN (Drug) $389.14
- UBRELVY (Drug) $370.49
- Rybelsus (Drug) $315.70
- Aimovig (Biological) $309.62
- Victoza (Drug) $308.09
- Cologuard Collection Kit (Device) $292.30
- REXULTI (Drug) $285.30
- ANORO (Drug) $284.24
- Kerendia (Drug) $266.13
- BREO (Drug) $260.07
- Prolia (Biological) $255.71
- SYMBICORT (Drug) $226.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hermitage
Richard Pak, Md, MD
Family Medicine — Payments: $20,563
Dr. Charles D'auria, D.o, D.O
Family Medicine — Payments: $19,203
Dr. Heather Porter, D.o, D.O
Family Medicine — Payments: $17,422
Mindi Hamby, Md, MD
Family Medicine — Payments: $15,709
Richard Stigliano
Family Medicine — Payments: $14,985
John Major, Md, MD
Family Medicine — Payments: $14,730